Naşide Gözde Durmuş

Naside Gözde Durmuş (born 1985, Izmir) is a Turkish scientist and geneticist.

Her research focuses on nanotechnology and micro-technology applications on current world-threatening health issues, like cancer and antibiotic resistance. The MIT Technology Review listed her under the category of pioneers in the magazine's "Innovators Under 35", as one of 35 young leaders in 2015.[1]

Biography

Durmuş was born in 1985 in Izmir, Turkey.[2] In 2003, she started her undergraduate studies at the Middle East Technical University, specializing in Molecular Biology and Genetics. Later on, she obtained a Fulbright scholarship and moved to the United States to pursue higher education, achieving a Masters in Engineering from Boston University in 2009, and receiving a Ph.D. degree in Biomedical Engineering from Brown University in May 2013.[3]

Durmus is currently an Assistant Professor at Stanford University. In 2014, she took a position as a post-doctoral researcher at Stanford University. She conducted her research with Ronald W. Davis at the Stanford University Genome Technology Center and Stanford School of Medicine.[4] In 2015, she has been recognized among the "Top 35 Innovators Under 35" (TR35), as a pioneer in biotechnology and medicine, by MIT Technology Review Magazine.

Career

Her work focuses on developing low-cost nanotechnology tools that can be used for the diagnose and treatment of diseases, like for instance a fast method for detecting the physical features of a cell, by having them levitate in a magnetic field, this being able to measure in a shorter period of time how a microbe responds to a certain drug,[1] and making it possible to differentiate cancerous cells from healthy ones.[5]

References

This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.